Cluster randomised trial comparing one versus two doses of ivermectin for mass drug administration to control scabies [ 2017 - ]

Research Grant

Researchers: Prof Andrew Steer (Principal investigator) ,  Dr Daniel Engelman ,  Dr Lucia Romani ,  Dr Margot Whitfeld ,  Dr Michael Marks
View all 9 related researchers

Brief description Scabies is a common skin disease in developing countries, in particular in the Pacific region. In the Western Province of Solomon Islands, one in two children suffer from the infestation, and 20% of the population. We know that mass drug administration with two doses of oral ivermectin is effective to reduce the burden of scabies in the community. We now propose a study to determine whether one single dose is as effective. This would have major public health benefits.

Funding Amount $540,512.00

Funding Scheme Project Grants

Notes Standard Project Grant